Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas A Fraunhoffer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancers|December 10, 2021
Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy InhibitionConsuelo Gajate, Odile Gayet, Nicolas A Fraunhoffer, et al.
Gene Expression|August 26, 2018
Biofabrication of Autologous Human Hepatocytes for Transplantation: How Do We Get There?Nandini Agarwal, Branimir Popovic, Nicole J Martucci, et al.
Journal of Ovarian Research|October 9, 2015
Identification of germ cell-specific VASA and IFITM3 proteins in human ovarian endometriosisNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Inés Stella, et al.
Plos One|September 8, 2018
Long-term apoptosis-related protein expression in the diabetic mouse ovaryNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Mariangel Aquino Barrientos, et al.
Cancers|December 24, 2021
DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based StudyInês Faleiro, Vânia Palma Roberto, Secil Demirkol Canli, et al.
NPJ Precision Oncology|August 17, 2022
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic predictionNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, et al.
Ebiomedicine|April 16, 2021
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistanceAbdessamad El Kaoutari, Nicolas A Fraunhoffer, Owen Hoare, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2021
Squamousness gain defines pancreatic ductal adenocarcinoma hepatic metastases phenotype, and gemcitabine responseNicolas A Fraunhoffer, Analia M Abuelafia, Carlos Teyssedou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor CarfilzomibNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, et al.
Ebiomedicine|May 31, 2023
Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markersAbdessamad El Kaoutari, Nicolas A Fraunhoffer, Stéphane Audebert, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancers|December 10, 2021
Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy InhibitionConsuelo Gajate, Odile Gayet, Nicolas A Fraunhoffer, et al.
Gene Expression|August 26, 2018
Biofabrication of Autologous Human Hepatocytes for Transplantation: How Do We Get There?Nandini Agarwal, Branimir Popovic, Nicole J Martucci, et al.
Journal of Ovarian Research|October 9, 2015
Identification of germ cell-specific VASA and IFITM3 proteins in human ovarian endometriosisNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Inés Stella, et al.
Plos One|September 8, 2018
Long-term apoptosis-related protein expression in the diabetic mouse ovaryNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Mariangel Aquino Barrientos, et al.
Cancers|December 24, 2021
DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based StudyInês Faleiro, Vânia Palma Roberto, Secil Demirkol Canli, et al.
NPJ Precision Oncology|August 17, 2022
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic predictionNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, et al.
Ebiomedicine|April 16, 2021
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistanceAbdessamad El Kaoutari, Nicolas A Fraunhoffer, Owen Hoare, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2021
Squamousness gain defines pancreatic ductal adenocarcinoma hepatic metastases phenotype, and gemcitabine responseNicolas A Fraunhoffer, Analia M Abuelafia, Carlos Teyssedou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor CarfilzomibNicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, et al.
Ebiomedicine|May 31, 2023
Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markersAbdessamad El Kaoutari, Nicolas A Fraunhoffer, Stéphane Audebert, et al.
Pageof 2